Alimera Sciences Inc (ALIM) Reports Significant Revenue Growth in Q4 and Full Year 2023 [Yahoo! Finance]
Alimera Sciences, Inc. (ALIM)
Last alimera sciences, inc. earnings: 4/29 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.alimerasciences.com/investor-relations
Company Research
Source: Yahoo! Finance
Adjusted EBITDA : Achieved approximately $5.0 million in Q4 2023, a significant improvement from a negative adjusted EBITDA in Q4 2022. Net Loss : Remained consistent at $(3.8) million for Q4 2023, compared to Q4 2022. 2024 Revenue Guidance : Increased, with expectations to deliver over $105 million in net revenue. Cash Position : Improved with cash and cash equivalents of approximately $12.1 million as of December 31, 2023. Warning! GuruFocus has detected 5 Warning Signs with ALIM. On March 7, 2024, Alimera Sciences Inc ( NASDAQ:ALIM ), a global pharmaceutical company specializing in retinal health, released its 8-K filing , announcing its financial results for the fourth quarter and full year of 2023. The company reported a significant increase in net revenues for both periods, with Q4 net revenues up 88% to $26.3 million compared to Q4 2022, and full-year net revenues up 49% to $80.8 million versus 2022. This growth is attributed to the successful marketing of ILUVIEN an
Show less
Read more
Impact Snapshot
Event Time:
ALIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALIM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALIM alerts
High impacting Alimera Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
ALIM
News
- Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate Update [Yahoo! Finance]Yahoo! Finance
- Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate UpdateGlobeNewswire
- Alimera Sciences, Inc. (NASDAQ: ALIM) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Alimera Sciences, Inc. (NASDAQ: ALIM) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Alimera Sciences, Inc. (NASDAQ: ALIM) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
ALIM
Earnings
- 3/7/24 - Miss
ALIM
Sec Filings
- 4/29/24 - Form 10-K/A
- 4/2/24 - Form 4
- 3/13/24 - Form 4
- ALIM's page on the SEC website